Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

NCT03854149 · clinicaltrials.gov ↗

COMPLETED

Status

218

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease
Atrial Arrhythmia
Thromboembolism
Anticoagulants Causing Adverse Effects in Therapeutic Use

Sponsor

AHEPA University Hospital

Collaborators

[object Object]
[object Object]
[object Object]